Author:
Bordoli M R,Stiehl D P,Borsig L,Kristiansen G,Hausladen S,Schraml P,Wenger R H,Camenisch G
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference52 articles.
1. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH et al. (2001). Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61: 2911–2916.
2. Balamurugan K, Luu VD, Kaufmann MR, Hofmann VS, Boysen G, Barth S et al. (2009). Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene 28: 3274–3285.
3. Barnard JA, Graves-Deal R, Pittelkow MR, DuBois R, Cook P, Ramsey GW et al. (1994). Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem 269: 22817–22822.
4. Barth S, Nesper J, Hasgall PA, Wirthner R, Nytko KJ, Edlich F et al. (2007). The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Mol Cell Biol 27: 3758–3768.
5. Brown JM, Wilson WR . (2004). Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437–447.
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献